Bacillus Calmette-Guérin immunisation at birth and morbidity among Danish children: A prospective, randomised, clinical trial

Contemporary Clinical Trials

Volumn 42, Issue , 2015, Pages 213-218

  Thøstesen, Lisbeth Marianne ^a   Nissen, Thomas Nørrelykke ^b   Kjærgaard, Jesper ^c   Pihl, Gitte Thybo ^a   Birk, Nina Marie ^b   Benn, Christine Stabell ^c,d   Greisen, Gorm ^e   Kofoed, Poul Erik ^a,e   Pryds, Ole ^b   Ravn, Henrik ^c,d   Jeppesen, Dorthe Lisbeth ^b   Aaby, Peter ^d   Stensballe, Lone Graff ^c,d  

^a KOLDING HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c University of Copenhagen   (Denmark)

^d STATENS SERUM INSTITUT   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Bacillus Calmette Gu rin; BCG vaccination; Children; Heterologous immunity; Non specific effects of vaccines; Randomised clinical trial

Indexed keywords

ANTIBODY; BCG VACCINE; CYTOKINE;

ABSCESS; ALLERGIC DISEASE; ANAPHYLAXIS; ARTICLE; B LYMPHOCYTE; BCG VACCINATION; BIRTH; BLOOD SAMPLING; CALCULATION; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOKINE RESPONSE; ECHOGRAPHY; ECZEMA; FECES; FEVER; FLOW CYTOMETRY; FOLLOW UP; GROWTH CURVE; HEADACHE; HOSPITALIZATION; HUMAN; IN VITRO STUDY; INCOME; INFANT; INFECTION; INFORMATION PROCESSING; INJECTION SITE ULCER; LYMPHADENITIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MULTICENTER STUDY; NEWBORN; OSTEITIS; OSTEOMYELITIS; PRESCRIPTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REGISTER; SAMPLE SIZE; STRUCTURED INTERVIEW; T LYMPHOCYTE SUBPOPULATION; TELEPHONE INTERVIEW; THYMUS; TREATMENT OUTCOME; CLINICAL TRIAL; DENMARK; DEVELOPED COUNTRY; FEMALE; HEALTH STATUS; HYPERSENSITIVITY; IMMUNOLOGY; MALE; METHODOLOGY;

BCG VACCINE; CYTOKINES; DENMARK; DEVELOPED COUNTRIES; FEMALE; HEALTH STATUS; HUMANS; HYPERSENSITIVITY; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; RESEARCH DESIGN;

EID: 84928326888     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2015.04.006     Document Type: Article

References (21)

1. Fine P.E.M., Carneiro I.A.M., Milstien J.B., Clements C.J. Issues relating to the use of BCG in immunization programmes. A discussion document 1999, WHO Department of Vaccines and Biologicals, (http://whqlibdoc.who.int/hq/1999/WHO_V&B_99.23.pdf).
2. Garly M.L., Martins C.L., Bale C., Balde M.A., Hedegaard K.L., Gustafson P., et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?. Vaccine 2003, 21(21-22):2782-2790.
3. Roth A., Gustafson P., Nhaga A., Djana Q., Poulsen A., Garly M.L., et al. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol 2005, 34(3):540-547. 10.1093/ije/dyh392.
4. Roth A., Sodemann M., Jensen H., Poulsen A., Gustafson P., Weise C., et al. Tuberculin reaction, BCG scar, and lower female mortality. Epidemiology 2006, 17(5):562-568. 10.1097/01.ede.0000231546.14749.ab.
5. Aaby P., Shaheen S.O., Heyes C.B., Goudiaby A., Hall A.J., Shiell A.W., et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000, 30(5):644-650.
6. Aaby P., Roth A., Ravn H., Napirna B.M., Rodrigues A., Lisse I.M., et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?. J Infect Dis 2011, 204(2):245-252. 10.1093/infdis/jir240.
7. Biering-Sorensen S., Aaby P., Napirna B.M., Roth A., Ravn H., Rodrigues A., et al. Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact. Pediatr Infect Dis J 2012, 31(3):306-308. 10.1097/INF.0b013e3182458289.
8. Mortz C.G., Lauritsen J.M., Bindslev-Jensen C., Andersen K.E. Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. Br J Dermatol 2001, 144(3):523-532.
9. Strachan D.P. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000, 55(Suppl. 1):S2-S10.
10. Marchant A., Goetghebuer T., Ota M.O., Wolfe I., Ceesay S.J., De Groote D., et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999, 163(4):2249-2255.
11. Obihara C.C., Beyers N., Gie R.P., Potter P.C., Marais B.J., Lombard C.J., et al. Inverse association between Mycobacterium tuberculosis infection and atopic rhinitis in children. Allergy 2005, 60(9):1121-1125. 10.1111/j.1398-9995.2005.00834.x.
12. Townley R.G., Barlan I.B., Patino C., Vichyanond P., Minervini M.C., Simasathien T., et al. The effect of BCG vaccine at birth on the development of atopy or allergic disease in young children. Ann Allergy Asthma Immunol 2004, 92(3):350-355. 10.1016/s1081-1206(10)61574-8.
13. Gruber C., Kulig M., Bergmann R., Guggenmoos-Holzmann I., Wahn U. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early Bacille Calmette-Guerin-vaccinated and nonvaccinated children. Pediatrics 2001, 107(3). E36.
14. Singh M., Das R.R., Kumar L., Kumar R. Bacille Calmette-Guerin vaccination is associated with lower prevalence of allergic diseases in Indian children. Am J Rhinol Allergy 2013, 27(4):e107-e112. 10.2500/ajra.2013.27.3940.
15. Linehan M.F., Nurmatov U., Frank T.L., Niven R.M., Baxter D.N., Sheikh A. Does BCG vaccination protect against childhood asthma? Final results from the Manchester Community Asthma Study retrospective cohort study and updated systematic review and meta-analysis. J Allergy Clin Immunol 2014, 133(3):688-695. [e14].
16. Steenhuis T.J., van Aalderen W.M., Bloksma N., Nijkamp F.P., van der Laag J., van Loveren H., et al. Bacille-Calmette-Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single-blind study. Clin Exp Allergy 2008, 38(1):79-85. 10.1111/j.1365-2222.2007.02859.x.
17. Andersen T.F., Madsen M., Jorgensen J., Mellemkjoer L., Olsen J.H. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999, 46(3):263-268.
18. Hasselbalch H., Jeppesen D.L., Engelmann M.D., Michaelsen K.F., Nielsen M.B. Decreased thymus size in formula-fed infants compared with breastfed infants. Acta Paediatr 1996, 85(9):1029-1032.
19. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993, 186(1):23-31.
20. Bricker D., Squires J. Ages & Stages Questionnaires: a parent-completed, child-monitoring system 1999, Paul H. Brookes Publishing Co, Baltimore, MD. 2nd ed.
21. Folkesundhed SIf Folkesundhedsrapporten Accessed 13.03.2015. http://www.si-folkesundhed.dk/upload/kap_30_b%C3%B8rn.pdf.